Latest News

Big multiple sclerosis breakthrough: Phase 1 trial safely resets patients' immune systems and reduces attack on myelin protein

A phase 1 clinical trial for the first treatment to reset the immune system of multiple sclerosis (MS) patients showed the therapy was safe and dramatically reduced patients' immune systems' reactivity to myelin by 50 to 75 percent. The therapy used billions of patients' own specially processed blood cells to create tolerance to myelin, the insulating layer that forms around nerves. In MS, the immune system attacks myelin. The approach left the normal immune system intact.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Daily marijuana use among U.S. college students highest since 1980

  • Researchers help identify the neural basis of multitasking

  • Studying the outliers: Researchers discover a gene variant that provides a delaying mechanism for Alzheimer's disease

  • Preterm birth linked with less wealth

  • Another way urate may protect against Parkinson's disease

  • Forgiving others protects women from depression, but not men

  • Math skills count for premature babies

  • Accuracy of dementia brain imaging must improve

  • Suicide-by-firearm rates shift in two states after changes in state gun laws

  • Timing of sleep just as important as quantity

  •